Indian shares set to open higher, tracking Asian peers

SelfRugger · 2026-03-30T00:04:35+00:00

Indian shares are expected to open higher following gains in Asian markets, boosted by strong Nvidia earnings. However, caution persists due to profit booking and lack of domestic triggers. Geopolitical developments and AI news are anticipated to influence market sentiment.

SelfRugger

2026-03-30 00:04:35

Abstract generation in progress

Indian shares set to open higher, tracking Asian peers

A view shows an oil pump jack outside Almetyevsk, in the Republic of Tatarstan, Russia July 14, 2025. REUTERS/Stringer · Reuters

Reuters

Thu, 26 February 2026 at 11:35 am GMT+9 1 min read

In this article:

NVDA

+1.41%

CL=F

+0.11%

Feb 26 (Reuters) - Indian shares will likely open higher on Thursday, tracking gains across Asian markets after robust Nvidia ‌earnings, though analysts see the overall mood remaining cautious ‌on intermittent profit booking and the absence of fresh domestic triggers.

The Gift Nifty futures were trading at 25,676 points as of 8:00 a.m. IST, indicating the benchmark Nifty 50 will open above Wednesday’s close of 25,482.5.

Both the benchmark indexes rose about 0.9% each in intraday trade on Wednesday, ‌but gave up most ⁠of those gains to finish only marginally higher, as selling emerged at higher levels.

Other Asian markets rose ⁠0.6%, tracking an overnight uptick in Wall Street equities, after Nvidia posted a 73% jump in quarterly revenue, beating estimates.[MKTS/GLOB]

Oil prices rose, hovering near seven-month highs, as investors gauged whether the U.S.-Iran nuclear talks ‌could avert a conflict that risks supply disruptions. [O/R]

“Looking ahead, geopolitical developments involving the U.S. and Iran, along with artificial intelligence and tariff related news flow, are likely to dictate market sentiment and near-term trajectory,” said Bajaj Broking Research.

Foreign portfolio investors bought Indian stocks worth ‌29.92 billion rupees ($329.4 million) on Wednesday, while domestic institutional investors inflows stood at 51.19 billion rupees, on a net basis, per provisional data from the NSE.

STOCKS TO ‌WATCH

** Zydus Lifesciences says it will launch generic versions of semaglutide injections for obesity and diabetes in India under three brand names.

** Shaily Engineering secures a contract worth about 4.23 billion rupees

** ‌Sanofi India posts a year-on-year drop in profit in the December quarter.

($1 = 90.8360 Indian rupees)

(Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sumana Nandy)

Terms and Privacy Policy

Privacy dashboard

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.